Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001209191-23-053983

Options or other derivatives

  • Director acquired 41,538 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Boylan James P Director 2023-10-27 Grant or award · Stock option (right to buy) +41,538 41,538 D
Loading xslF345X05/doc4.xml…